Big Pharma Gets its Hooks into Seton Hall Law School
For decades, the pharmaceutical industry has marinated the medical profession in millions of dollars of free samples, lunches, trips, and fees.The goal -- influence, power, profits.
Now, the industry has another target -- the legal profession.
For decades, the pharmaceutical industry has marinated the medical profession in millions of dollars of free samples, lunches, trips, and fees.The goal -- influence, power, profits.
Now, the industry has another target -- the legal profession.
Last week, industry leaders Schering-Plough Corporation, sanofi-aventis, Johnson & Johnson and Bristol Myers Squibb and the pharma law firm Gibbons PC -- announced that they will donate a total of $9.1 million to establish the Center for Health & Pharmaceutical Law at Seton Hall Law School in Newark, New Jersey.
"This is what they have been doing with doctors for the last five decades -- shaping young doctors' minds," said Peter Rost, a former vice president at Pfizer and author of The Whistleblower: Confessions of a Healthcare Hitman (Soft Skull Press, 2006). "Now they want to shape the minds of young lawyers."
"I would imagine that the drug industry feels that the legal environment has been challenging -- with prosecutions and False Claims Act cases proliferating," Rost said. "I'm sure they hope that they can have an impact on things. They are not doing this to be nice. They are doing it because it is in their interest. They are making friends, trying to start being proactive about what happens -- get involved from the beginning."
A spokesperson for Seton Hall Law School, Kathleen Eagan, said she could not provide anyone for an interview about the project -- although last week, the Law School did distribute a press release and held a press conference about the donations.
Bristol Myers Squibb's contribution -- $5 million -- grew out of a June 2005 deferred prosecution agreement cut with the U.S. Attorney in New Jersey -- Christopher Christie -- a Seton Hall Law School graduate.
Christie has been harshly criticized for directing the funds to his alma mater.
But he says that the idea came from the lawyer representing Bristol Myers Squibb and that his office only required that a business ethics chair be endowed at a New Jersey law school.
Lo and behold, Rutgers University School of Law already had a business ethics chair -- endowed by Prudential.
Christie says that Bristol Myers was required to endow the chair in an effort to "change the corporate culture."
How?
"The professor occupying that endowed chair is required to conduct an annual ethics seminar for Bristol-Myers management and other interested industry members," Christie said last year.
(c) 2007 Corporate Crime Reporter.com
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission has always been simple: To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It's never been this bad out there. And it's never been this hard to keep us going. At the very moment Common Dreams is most needed, the threats we face are intensifying. We need your support now more than ever. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Will you donate now to make sure Common Dreams not only survives but thrives? —Craig Brown, Co-founder |
For decades, the pharmaceutical industry has marinated the medical profession in millions of dollars of free samples, lunches, trips, and fees.The goal -- influence, power, profits.
Now, the industry has another target -- the legal profession.
Last week, industry leaders Schering-Plough Corporation, sanofi-aventis, Johnson & Johnson and Bristol Myers Squibb and the pharma law firm Gibbons PC -- announced that they will donate a total of $9.1 million to establish the Center for Health & Pharmaceutical Law at Seton Hall Law School in Newark, New Jersey.
"This is what they have been doing with doctors for the last five decades -- shaping young doctors' minds," said Peter Rost, a former vice president at Pfizer and author of The Whistleblower: Confessions of a Healthcare Hitman (Soft Skull Press, 2006). "Now they want to shape the minds of young lawyers."
"I would imagine that the drug industry feels that the legal environment has been challenging -- with prosecutions and False Claims Act cases proliferating," Rost said. "I'm sure they hope that they can have an impact on things. They are not doing this to be nice. They are doing it because it is in their interest. They are making friends, trying to start being proactive about what happens -- get involved from the beginning."
A spokesperson for Seton Hall Law School, Kathleen Eagan, said she could not provide anyone for an interview about the project -- although last week, the Law School did distribute a press release and held a press conference about the donations.
Bristol Myers Squibb's contribution -- $5 million -- grew out of a June 2005 deferred prosecution agreement cut with the U.S. Attorney in New Jersey -- Christopher Christie -- a Seton Hall Law School graduate.
Christie has been harshly criticized for directing the funds to his alma mater.
But he says that the idea came from the lawyer representing Bristol Myers Squibb and that his office only required that a business ethics chair be endowed at a New Jersey law school.
Lo and behold, Rutgers University School of Law already had a business ethics chair -- endowed by Prudential.
Christie says that Bristol Myers was required to endow the chair in an effort to "change the corporate culture."
How?
"The professor occupying that endowed chair is required to conduct an annual ethics seminar for Bristol-Myers management and other interested industry members," Christie said last year.
(c) 2007 Corporate Crime Reporter.com
For decades, the pharmaceutical industry has marinated the medical profession in millions of dollars of free samples, lunches, trips, and fees.The goal -- influence, power, profits.
Now, the industry has another target -- the legal profession.
Last week, industry leaders Schering-Plough Corporation, sanofi-aventis, Johnson & Johnson and Bristol Myers Squibb and the pharma law firm Gibbons PC -- announced that they will donate a total of $9.1 million to establish the Center for Health & Pharmaceutical Law at Seton Hall Law School in Newark, New Jersey.
"This is what they have been doing with doctors for the last five decades -- shaping young doctors' minds," said Peter Rost, a former vice president at Pfizer and author of The Whistleblower: Confessions of a Healthcare Hitman (Soft Skull Press, 2006). "Now they want to shape the minds of young lawyers."
"I would imagine that the drug industry feels that the legal environment has been challenging -- with prosecutions and False Claims Act cases proliferating," Rost said. "I'm sure they hope that they can have an impact on things. They are not doing this to be nice. They are doing it because it is in their interest. They are making friends, trying to start being proactive about what happens -- get involved from the beginning."
A spokesperson for Seton Hall Law School, Kathleen Eagan, said she could not provide anyone for an interview about the project -- although last week, the Law School did distribute a press release and held a press conference about the donations.
Bristol Myers Squibb's contribution -- $5 million -- grew out of a June 2005 deferred prosecution agreement cut with the U.S. Attorney in New Jersey -- Christopher Christie -- a Seton Hall Law School graduate.
Christie has been harshly criticized for directing the funds to his alma mater.
But he says that the idea came from the lawyer representing Bristol Myers Squibb and that his office only required that a business ethics chair be endowed at a New Jersey law school.
Lo and behold, Rutgers University School of Law already had a business ethics chair -- endowed by Prudential.
Christie says that Bristol Myers was required to endow the chair in an effort to "change the corporate culture."
How?
"The professor occupying that endowed chair is required to conduct an annual ethics seminar for Bristol-Myers management and other interested industry members," Christie said last year.
(c) 2007 Corporate Crime Reporter.com